Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Within the past year, Dr Daniel Javitt has served as a consultant to Sepracor, AstraZeneca, Pfizer, Cypress Bioscience, Merck, Sunovion, Eli Lilly, and BMS, and has received research support from Pfizer, Roche, and Jazz Pharmaceuticals
Socioeconomic factors were represented by problems associated with housing and economic circumstances (Z59)
doi: 10.4239/wjd.v12.i7.916 28 LattNDoreG
The American Heart Association (AHA) guidelines suggest the initiation of SGLT-2i or GLP-1RA in patients with T2DM who have additional cardiovascular risk factors [14]
J Control Release 383:113769
US$ 27.31
US$ 25.11
US$ 21.38
US$ 25.23
US$ 27.26
